300 related articles for article (PubMed ID: 8431161)
1. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group.
Keltner JL; Johnson CA; Spurr JO; Beck RW
Arch Ophthalmol; 1993 Feb; 111(2):231-4. PubMed ID: 8431161
[TBL] [Abstract][Full Text] [Related]
2. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial.
Keltner JL; Johnson CA; Spurr JO; Beck RW
Arch Ophthalmol; 1994 Jul; 112(7):946-53. PubMed ID: 8031275
[TBL] [Abstract][Full Text] [Related]
3. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
Beck RW; Kupersmith MJ; Cleary PA; Katz B
Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012
[TBL] [Abstract][Full Text] [Related]
4. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.
Keltner JL; Johnson CA; Cello KE; Dontchev M; Gal RL; Beck RW;
Arch Ophthalmol; 2010 Mar; 128(3):330-7. PubMed ID: 20212204
[TBL] [Abstract][Full Text] [Related]
5. [Recovery of visual field defects in ischemic optic neuropathy and idiopathic optic neuritis].
Watanabe I; Iijima H; Imai M
Nippon Ganka Gakkai Zasshi; 1991 Oct; 95(10):986-94. PubMed ID: 1746375
[TBL] [Abstract][Full Text] [Related]
6. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial.
Keltner JL; Johnson CA; Spurr JO; Beck RW
Am J Ophthalmol; 1999 Nov; 128(5):543-53. PubMed ID: 10577521
[TBL] [Abstract][Full Text] [Related]
7. Inapparent visual field defects in multiple sclerosis patients.
Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
[TBL] [Abstract][Full Text] [Related]
8. Global visual field involvement in acute unilateral optic neuritis.
Fang JP; Donahue SP; Lin RH
Am J Ophthalmol; 1999 Nov; 128(5):554-65. PubMed ID: 10577522
[TBL] [Abstract][Full Text] [Related]
9. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features.
Gerling J; Meyer JH; Kommerell G
Graefes Arch Clin Exp Ophthalmol; 1998 Mar; 236(3):188-92. PubMed ID: 9541821
[TBL] [Abstract][Full Text] [Related]
10. Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.
Feldon SE
Trans Am Ophthalmol Soc; 2004; 102():269-303. PubMed ID: 15747764
[TBL] [Abstract][Full Text] [Related]
11. Contrast sensitivity and other vision tests in the optic neuritis treatment trial.
Trobe JD; Beck RW; Moke PS; Cleary PA
Am J Ophthalmol; 1996 May; 121(5):547-53. PubMed ID: 8610798
[TBL] [Abstract][Full Text] [Related]
12. Visual field defects in acute optic neuritis--distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution.
Nevalainen J; Krapp E; Paetzold J; Mildenberger I; Besch D; Vonthein R; Keltner JL; Johnson CA; Schiefer U
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):599-607. PubMed ID: 18239928
[TBL] [Abstract][Full Text] [Related]
13. Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time.
Scherer RW; Feldon SE; Levin L; Langenberg P; Katz J; Keyl PM; Wilson PD; Kelman SE; Dickersin K;
Ophthalmology; 2008 Oct; 115(10):1809-17. PubMed ID: 18486224
[TBL] [Abstract][Full Text] [Related]
14. Anterior ischemic optic neuropathy in eyes with optic disc drusen.
Purvin V; King R; Kawasaki A; Yee R
Arch Ophthalmol; 2004 Jan; 122(1):48-53. PubMed ID: 14718294
[TBL] [Abstract][Full Text] [Related]
15. High-pass resolution perimetry in optic neuritis.
Wall M
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2525-9. PubMed ID: 1869407
[TBL] [Abstract][Full Text] [Related]
16. MRI texture heterogeneity in the optic nerve predicts visual recovery after acute optic neuritis.
Zhang Y; Metz LM; Scott JN; Trufyn J; Fick GH; Costello F
Neuroimage Clin; 2014; 4():302-7. PubMed ID: 25061567
[TBL] [Abstract][Full Text] [Related]
17. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
18. Acute ganglion cell loss during rapid visual recovery in optic neuritis.
Fukuchi M; Kishi S; Li D; Akiyama H
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2355-2360. PubMed ID: 27299339
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Schinzel J; Schwarzlose L; Dietze H; Bartusch K; Weiss S; Ohlraun S; Paul F; Dörr J
Trials; 2012 Jun; 13():94. PubMed ID: 22742888
[TBL] [Abstract][Full Text] [Related]
20. Optic neuritis: correlation of pain and magnetic resonance imaging.
Fazzone HE; Lefton DR; Kupersmith MJ
Ophthalmology; 2003 Aug; 110(8):1646-9. PubMed ID: 12917187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
